Search Results
Found 7 results
510(k) Data Aggregation
(477 days)
CAE
The LMA Unique™, LMA Classic™, LMA Classic Excel™, LMA Flexible™, LMA Flexible™ Single Use, LMA ProSeal™, LMA Fastrach™ Single Use, and LMA Supreme™ are devices inserted into a patient's pharynx through the mouth to provide a patent airway. These can be used in a Magnetic Resonance (MR) environment, not to exceed a 3.0 Tesla static magnetic field.
The LMA Fastrach™ ETT (reusable) and LMA Fastrach™ ETT Single Use are indicated for airway management by oral intubation of the trachea. Reinforced ETT may be used to reduce the potential for kinking whenever an unusual positioning of the head or neck is required following intubation. These can be used in a Magnetic Resonance (MR) environment, not to exceed a 3.0 Tesla static magnetic field.
The LMA™ family of airways includes 2 types of airways: Generically referred to as supraglottic airways and Tracheal Tubes specific for use with the LMA Fastrach™ device. The supraglottic airways are airways that incorporate a large cuff that sits above the glottic opening and the opposite end has a standard 15 mm OD connector that connector to a gas source. The LMA Flexible™ is the same as the Classic™ except that the shaft is wire reinforced allowing for great flexibility. The LMA ProSeal™ which has a second lumen for drainage. The LMA Fastrach™ single use which has a rigid handle to assist with insertion. The LMA Fastrach™ ETT and LMA Fastrach™ ETT Single Use is straight, cuffed, wire reinforced tracheal tube that is designed to be used with the LMA Fastrach™ supraglottic airway.
The provided 510(k) summary focuses on demonstrating the MR Conditional environment of use for various LMA airway devices and tracheal tubes. It does not contain information about studies related to diagnostic performance, accuracy, or human reader improvement with AI assistance. The "acceptance criteria" and "device performance" in this context refer to engineering and safety specifications related to MRI compatibility, not clinical diagnostic metrics.
Here's a breakdown of the requested information based on the document:
1. Table of Acceptance Criteria and Reported Device Performance
Acceptance Criteria (Set by ASTM F2052-06e1) | Reported Device Performance (as stated in the document) |
---|---|
No new risks associated with MR Conditional use. | Bench testing per ASTM F2502-06e1 demonstrated that the devices meet the pass/fail criteria. |
Magnetic field-induced displacement force should not pose a hazard. | Devices meet the requirements, with additional instructions for fixation (taping, cloth, or plastic holding device) for those exceeding 45 degrees deflection. |
Performance of the inflation check valve during and after MRI exposure should not be affected. | "There was no affects [sic]" on the check valve performance. |
2. Sample Size Used for the Test Set and Data Provenance
- Sample Size for Test Set: The document mentions testing on "4 models of the LMA™ devices" (LMA ProSeal™, LMA Fastrach™ ETT, LMA Supreme™, LMA Flexible™). It also states that other models (LMA Classic™, LMA Unique™, LMA Classic Excel™, and LMA Fastrach™ Single Use) were deemed substantially equivalent based on the LMA Supreme™'s results due to similar complete plastic, non-magnetic materials (except for the check valve). The exact number of individual units tested within these models is not specified.
- Data Provenance: Not applicable in the traditional sense of clinical data. This refers to bench testing conducted according to a specific ASTM standard (F2052-06e1) to assess MRI compatibility. The country of origin of this specific testing data is not specified, but the submission is to the FDA (USA). The testing is non-clinical.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts
Not applicable. The ground truth for this type of test is defined by the technical specifications and pass/fail criteria of the ASTM F2052-06e1 standard for magnetically induced displacement force and material compatibility in an MRI environment. It does not involve human experts establishing a "ground truth" for clinical diagnoses.
4. Adjudication Method for the Test Set
Not applicable. The assessment is based on objective measurements against the ASTM F2052-06e1 standard, not on human interpretation or adjudication.
5. If a Multi Reader Multi Case (MRMC) Comparative Effectiveness Study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
No. This 510(k) submission is for the MRI compatibility of medical devices, not for a diagnostic AI system. Therefore, an MRMC comparative effectiveness study is not relevant and was not conducted.
6. If a Standalone (i.e. algorithm only without human-in-the-loop performance) was done
Not applicable. This device is a physical medical device, not an algorithm.
7. The Type of Ground Truth Used
The ground truth used is the physical properties and behavior of the devices as measured against the pass/fail criteria defined by the ASTM F2052-06e1 standard. This standard is an engineering specification for assessing magnetic field-induced displacement force and other MRI compatibility factors for medical devices.
8. The Sample Size for the Training Set
Not applicable. There is no AI algorithm being trained in this context. The study involves bench testing of physical devices.
9. How the Ground Truth for the Training Set was Established
Not applicable. There is no AI algorithm or training set involved.
Ask a specific question about this device
(216 days)
CAE
The KING LTS is intended for use in adult patients (in excess of 25 kg) for controlled ventilation during anesthesia for procedures that are short in duration oonlour vehilation is considered to have a low risk of aspiration of stomach contents.
Tube with two attached, inflatable balloons. Ventilation openings between the balloons. Can be sterilized in an autoclave. Proximal ISO Standard 15mm connector for attachment to breathing circuit. Medical grade polymers or approved materials for all components in contact with the anesthesia gas stream. Connected to a Breathing Circuit. Inserted blindly. Seals the esophagus. Cuffs are inflated with one inflation port. Instructions that patient should have fasted before using the product. Latex free product.
Here's a breakdown of the acceptance criteria and study information based on the provided text, recognizing this is a 510(k) premarket notification for a Class I device seeking substantial equivalence, not a detailed clinical trial report.
Acceptance Criteria and Reported Device Performance
The provided document describes a 510(k) submission seeking substantial equivalence to a predicate device (King Systems Corporation KLT Oropharyngeal Airway, 510(k) #K021634). For devices seeking substantial equivalence, the "acceptance criteria" are generally that the new device performs as well as or similarly to the predicate device, especially regarding performance characteristics relevant to its intended use and safety. The study provided here is primarily a comparison to the predicate device, demonstrating that the design and certain performance characteristics are "substantially equivalent."
Table of Acceptance Criteria and Reported Device Performance
Since this is a substantial equivalence submission, the acceptance criteria are implicit: the new device's characteristics should match or be demonstrably similar to the predicate device. The "reported device performance" is the comparison data presented.
Characteristic | Acceptance Criteria (from predicate) | KING LTSTM (New Device) Performance | Comparison |
---|---|---|---|
Intended Use | Ventilation during anesthesia during procedures of short duration. An oropharyngeal airway is a device inserted through the mouth to provide a patent airway. | Same as predicate (Yes) | Meets criteria by being identical. |
Design | Tube with two attached, inflatable balloons | Yes | Meets criteria by being identical. |
Ventilation openings between the balloons | Yes | Yes | Meets criteria by being identical. |
Can be sterilized in an autoclave | Yes | Yes | Meets criteria by being identical. |
Proximal ISO Standard 15mm connector for attachment to breathing circuit | Yes | Yes | Meets criteria by being identical. |
Medical grade polymers or approved materials for all components in contact with the anesthesia gas stream | Yes | Identical to materials in predicate device | Meets criteria by being identical. |
Summary of Features: Connected to a Breathing Circuit | Yes | Yes | Meets criteria by being identical. |
Internal Volume (dead space) (ml)* | 9.0 | 8.7 | Difference: 0.3 ml. The submission implies this is proportionally, approximately equal. |
Resistance cmH2O @ 30 L/min* | 1.3 | 1.6 | Difference: 0.3 cmH2O. The submission implies this is proportionally, approximately equal. |
Weight (gm)* | 32.2 | 51.3 | Difference: 19.1 gm. This is a noticeable difference, but for a Class I device and the context of substantial equivalence, it's likely deemed acceptable if it doesn't impact safety or effectiveness. |
Prescription use only? | Yes | Yes | Meets criteria by being identical. |
Inserted blindly? | Yes | Yes | Meets criteria by being identical. |
Enters the trachea? | No | No | Meets criteria by being identical. |
Seals the esophagus? | Yes | Yes | Meets criteria by being identical. |
Cuffs are inflated with one inflation port? | Yes | Yes | Meets criteria by being identical. |
Instructions that patient should have fasted before using the product? | Yes | Yes | Meets criteria by being identical. |
Latex free product | Yes | Yes | Meets criteria by being identical. |
Product classification | CAE | CAE | Meets criteria by being identical. |
*Comparison values are for Size 4. |
Study Information
The provided document is a 510(k) premarket notification for a Class I device establishing substantial equivalence to an existing predicate device. This type of submission, especially for Class I devices, typically relies on demonstrated comparability through engineering testing and material analysis rather than extensive human clinical trials.
-
Sample size used for the test set and the data provenance:
- The "test set" in this context refers to the specific device characteristics measured for the KING LTS™ (new device) and compared to the KING LT™ (predicate device).
- Specific sample sizes for the measurements of internal volume, resistance, and weight are not explicitly stated (e.g., "n=X devices were tested for resistance"). However, the comparison is made on "Size 4 for both the KING LTS™ and the KING LT™," implying that at least one unit of each size 4 device was used for these measurements. It's likely that a small number of devices were tested per characteristic to ensure consistency.
- Data Provenance: The data appears to be from internal manufacturer testing ("Manufacturer's tests have shown the device to successfully withstand fifty or more cleaning and autoclave sterilization cycles."). The country of origin for the new product is Germany ("Product manufactured in Germany is new to U.S. market.").
-
Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
- This question is not applicable to this type of 510(k) submission. "Ground truth" for diagnostic or AI devices is typically established by multiple experts. For this device (an oropharyngeal airway), the "truth" is established by direct measurement of physical and performance characteristics, and by clinical consensus on its intended use and safety profile, which are aligned with the predicate. No expert panels for ground truth determination are described.
-
Adjudication method for the test set:
- Not applicable. There is no expert adjudication described for the physical and performance measurements reported.
-
If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
- Not applicable. This is not an AI-powered diagnostic device, and therefore, no MRMC study or AI assistance evaluation was conducted or described.
-
If a standalone (i.e., algorithm only without human-in-the-loop performance) was done:
- Not applicable. This is not an AI algorithm.
-
The type of ground truth used (expert consensus, pathology, outcomes data, etc.):
- The "ground truth" for this device's performance is based on engineering measurements and specifications (e.g., internal volume, resistance, weight, material composition, sterilization capabilities) and alignment with established medical device standards (e.g., ISO 5356-1, ASTM F1242-96) and regulatory classifications (CAE - 21 CFR 868.5110). Clinical "ground truth" is implied by its similarity to an already legally marketed and accepted predicate device with a known safety and effectiveness profile.
-
The sample size for the training set:
- Not applicable. This is not a machine learning or AI device that requires a training set.
-
How the ground truth for the training set was established:
- Not applicable. As this is not an AI device, there is no training set or ground truth for such a set.
Ask a specific question about this device
(196 days)
CAE
The KING LT-D is intended for use in adult patients (in excess of 25 kg) for controlled ventilation during anesthesia for procedures that are short in duration and when the patient is considered to have a low risk of aspiration of stomach contents.
Each device is constructed of medical grade elastomeric and thermoplastic materials. All fittings conform to ISO 5356-1/1996: Anesthetic and Respiratory Equipment - Conical Connectors; Part 1 Cones and Sockets. The device incorporates the following components or features:
- . Bi-directional gas flow through a ventilation channel.
- Inflatable bladders to assist in maintenance of placement and in sealing the . airway from the stomach and from the atmosphere
- . Indicators for proper placement permanently printed on the tube
- A rigid plastic connector complying with ISO standards for the 15mm connection . to the patient end of a breathing circuit.
This document describes a premarket notification (510(k)) for the KING LT-D Disposable Oropharyngeal Airway, not an AI device. Therefore, many of the requested criteria (e.g., sample sizes for test/training sets, expert ground truth, MRMC studies, standalone performance, software validation) are not applicable.
The document focuses on demonstrating substantial equivalence to a predicate device for a disposable version of an existing product. The acceptance criteria are related to material properties, design conformity, and intended use, rather than performance metrics of an AI algorithm.
1. A table of acceptance criteria and the reported device performance
Characteristic | Acceptance Criteria (based on predicate) | KING LT-D Performance (reported) |
---|---|---|
Intended Use: Ventilation during anesthesia during procedures of short duration. An oropharyngeal airway is a device inserted through the mouth to provide a patent airway. | Yes | Yes |
Design: Tube with two attached, inflatable balloons | Yes | Yes |
Ventilation openings between the balloons | Yes | Yes |
Sterile device indicated for single patient use. | No (for predicate) | Yes |
ISO Standard 15 mm proximal connector for attachment to breathing circuit | Yes | Yes |
Medical grade polymers or approved materials for all components in contact with the anesthesia gas stream. | Yes | Yes |
Connected to a Breathing Circuit | Yes | Yes |
11.5 mm internal diameter | Yes | Yes |
Weight (gm) | 32.2 (predicate) | 32.1 |
Prescription use only? | Yes | Yes |
Inserted blindly? | Yes | Yes |
Enters the trachea? | No | No |
Seals the esophagus? | Yes | Yes |
Cuffs are inflated with one inflation port? | Yes | Yes |
Instructions that patient should have fasted before using the product? | Yes | Yes |
Latex free product | Yes | Yes |
Product classification | CAF (predicate) | CAE |
Materials in conformity with voluntary standards (ISO 5356-1/1996, ASTM F1242-96, EN30993/ISO 10993) | Utilized in whole or in part | Yes (stated in text) |
Biocompatibility | Equivalent to other medical devices | Yes (stated in text) |
All verification and validation activities demonstrated that the predetermined acceptance criteria were met. | Yes | Yes (stated in text) |
Conformance with design control procedure requirements as specified in 21 CFR 820.30 | Yes | Yes (stated in text) |
Study Proving Acceptance Criteria:
The study proving the device meets the acceptance criteria is a premarket notification (510(k)) submission demonstrating substantial equivalence to a legally marketed predicate device (King Systems Corporation KLT Oropharyngeal Airway, 510(k) #K021634).
The acceptance criteria are primarily met by:
- Direct comparison of characteristics (e.g., intended use, design, dimensions, materials, sterile status) to the predicate device.
- Compliance with recognized standards: ISO 5356-1/1996-12-15, ASTM F1242-96, and EN30993/ISO 10993 for biocompatibility.
- Risk analysis and verification/validation activities: The document states that "the designated individual(s) performed all verification and validation activities and the results of the activities demonstrated that the predetermined acceptance criteria were met."
- Conformance with design control procedures as per 21 CFR 820.30.
2. Sample sized used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)
Not applicable. This is a medical device submission based on substantial equivalence to a predicate, not a study involving a test set of data in the context of an AI/software device. The product is manufactured in Malaysia.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)
Not applicable. This device is not software driven and does not involve AI or the establishment of ground truth by experts in the sense of diagnostic accuracy studies.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
Not applicable. There is no test set or adjudication process described for this device.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
Not applicable. This is not an AI-assisted device.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
Not applicable. This is not an AI algorithm. The document explicitly states: "This device is not software driven. Software validation and verification is not applicable."
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)
Not applicable in the context of an AI device. For this medical device, the "ground truth" or basis for acceptance is primarily the characteristics and performance of the legally marketed predicate device and compliance with established international and ASTM standards for design, materials, and intended use.
8. The sample size for the training set
Not applicable. This is a medical device, not an AI model requiring a training set.
9. How the ground truth for the training set was established
Not applicable, as there is no training set for this type of device.
Ask a specific question about this device
(237 days)
CAE
The KING LT oropharyngeal airway is intended for use in adult patients for controlled ventilation during anesthesia for procedures of short duration, when the patient is considered to have a low risk of aspiration of stomach contents.
Not Found
This document is a 510(k) clearance letter from the FDA for a medical device called the "KING LTTM" oropharyngeal airway. It states that the device is substantially equivalent to legally marketed predicate devices.
However, the provided text does not contain any information regarding acceptance criteria, device performance metrics, or study details such as sample sizes, data provenance, expert qualifications, adjudication methods, MRMC studies, standalone performance, or ground truth establishment.
Therefore, I cannot fulfill your request for that specific information based on the text provided. This document is a regulatory approval notice, not a study report.
Ask a specific question about this device
(466 days)
CAE
Not Found
Not Found
The provided text describes a medical device, the COPA™ (Cuffed Oropharyngeal Airway), and a series of studies evaluating its performance. The text discusses preliminary feasibility studies, design modifications, functional (bench) testing, and several clinical studies.
It's important to note that this document is a summary and lacks specific acceptance criteria in a formal, quantitative manner that would be typical for a device's regulatory approval against pre-defined performance goals. Instead, the "acceptance criteria" are implied by the comparative nature of the studies against predicate devices (LMA, face mask/Guedel airway) and the general assessment of safety and effectiveness.
Given the information, here's an attempt to structure the response as requested, interpreting implied acceptance criteria from the study goals and findings:
1. Table of Implied Acceptance Criteria and Reported Device Performance
Implied Acceptance Criterion | COPA™ Performance (Reported) | Notes / Source |
---|---|---|
A. Functional and Design Conformance | ||
1. Conformance to ISO 5364 (Oropharyngeal airways) requirements | Verified conformance to: molding tolerances, dimensions of 15mm connectors and airway, resistance to collapse of the buccal end, resistance to distortion. | Functional Testing (Bench testing of sterile prototypes) |
2. Airway integrity and consistency (e.g., cuff, bond strength) | Verified: airway integrity, resting volumes and diameters of cuffs, cuff integrity, cuff herniation over distal end, strength of tail-airway bond, disconnect force of connector from breathing circuitry. | Functional Testing (Bench testing of sterile prototypes) |
3. Appropriate placement and airway occlusion | Cuff appropriately placed in the pharynx; when inflated, it occludes the nasopharynx, displaces tongue base/epiglottis anteriorly, and seals posterior pharynx. Does not extend past the vallecula or into the esophagus, avoiding glottic/tracheal stimulation. | Functional Testing (Cadaver studies - compared to predicate devices) |
4. Cuff seals at lower pressures than predicate devices | Cuff seals the oropharynx at lower pressures than both the Sheridan Combi-Tube and Laryngeal Mask Airway. | Functional Testing (Cadaver studies - compared to predicate devices) |
B. Clinical Effectiveness - Airway Maintenance & Ease of Use | ||
1. Easy device placement and maintenance of patent airway | "Device placement and maintenance of a patent airway were easy." (European Study) | |
Provided a clear airway in 98% (MAB), 100% (SB), 100% (emergence from anesthesia) in the Australian study. | ||
Equivalent to LMA in ease of use (Randomized Controlled Study). | Clinical Study A (European), Clinical Study B (Australian), Clinical Study C (Randomized Controlled) | |
2. Anesthetic doses comparable to predicate devices | "Anesthetic doses needed for device placement and maintenance are similar to those needed for the predicate devices." | Clinical Study A (European) |
3. Time to hands-free airway (compared to LMA) | 229 seconds (COPA) vs 137 seconds (LMA). Significantly longer for COPA (p=0.004). | Clinical Study C (Randomized Controlled) |
4. Proportion of patients achieving hands-free airway (compared to LMA) | 9.6% (29/302) did not achieve hands-free airway with COPA vs 0.66% (1/150) with LMA. Significantly higher for COPA (p2 or continuous support) vs 0% (LMA). Total (%) 0 Manipulations: COPA 45.8% vs LMA 96%. "Although the LMA was associated with fewer airway manipulations, both devices were equivalent in establishing a safe and effective airway." | |
Australian study indicates 21.4% required jaw lift during SB. | Clinical Study C (Randomized Controlled) - Table "Airway Manipulations", Clinical Study B (Australian) | |
6. Time to spontaneous breathing (compared to LMA) | COPA 7.3 minutes vs LMA 6.7 minutes. Not significantly different (p=0.44). | Clinical Study C (Randomized Controlled) |
C. Clinical Safety & Complication Rates | ||
1. Minor anesthetic sequelae comparable to predicate devices | "Anesthetic sequelae (coughing, bucking, and sore throat) were minor and comparable to those occurring with use of tracheal tubes and laryngeal mask airways." | |
Mild sore throat occurred in 4% (Australian study). | Clinical Study A (European), Clinical Study B (Australian) | |
2. Overall physiological tolerance and complications comparable to LMA (main study) | Equivalent to LMA in physiological tolerance and minor/major complications. No unanticipated adverse device effects or life-threatening problems/deaths. | Clinical Study C (Randomized Controlled) |
3. Specific adverse events comparable to LMA (main study) | No significant difference (p>0.05) for: Aspiration, regurgitation, laryngospasm, succinylcholine given, wheeze, hypoxia (SaO2 |
Ask a specific question about this device
(94 days)
CAE
The Rusch Optosafe, sterile, for oral insertion to provide an airway though the patient's mouth and allow fiberoptic tracheal intubation is substantially equivlent in design, use and materials to the Williams Airway Intubator K830767 currently being marketed and sold in inter-state commerce.
The device is designed as a single use, sterile, oropharyngeal airway to maintain a patent airway through the mouth to the pharynx and allow fiberoptic tracheal intubation.
The device consists of a clear, implant tested, PVC tube formed into the conventional hooked shape of an oral airway. The tube is bonded with a polyurethane adhesive to a clear implant tested PVC bite block and flange molding. The flange is printed with the manufacturer's name, date code and size (nominal inner diameter of tube).
Here's a breakdown of the requested information based on the provided text, which appears to be a 510(k) summary for a medical device.
Crucial Caveat: The provided document is a 510(k) Pre-market Notification Summary, specifically for the "Rusch Optosafe." This type of document aims to establish substantial equivalence to a predicate device, not necessarily to present a detailed study with acceptance criteria and performance metrics in the way a clinical trial or AI device validation study would. Therefore, much of the requested information is not present in this type of regulatory submission. The document explicitly states: "Based upon the equivalence in materials, design and intended use between this tube and others presently being marketed and sold, no difference in safety and effectiveness is forecasted." This means the assessment relies on the predicate device's existing performance, not a new, independent performance study of the Optosafe itself.
Acceptance Criteria and Study to Prove Device Meets Criteria
Given the nature of the document, a traditional "acceptance criteria" table and a "study"proving the device meets those criteria, as one would expect for an AI/diagnostic device, are not detailed. The acceptance criterion for a 510(k) is typically substantial equivalence to a legally marketed predicate device.
1. Table of Acceptance Criteria and Reported Device Performance
Acceptance Criteria (Stated/Implied for 510(k)) | Reported Device Performance (Implied from Substantial Equivalence Claim) |
---|---|
Safety: Device presents no new safety risks. | "no difference in safety... is forecasted" compared to predicate. |
Effectiveness: Device performs as intended. | "no difference in ... effectiveness is forecasted" compared to predicate. |
Intended Use: Matches predicate device. | "substantially equivalent in design, use and materials" to predicate. |
Design: Similar to predicate device. | "substantially equivalent in design..." to predicate. |
Materials: Similar to predicate device. | "substantially equivalent in ... materials" to predicate. |
Note: The document does not provide quantitative performance metrics (e.g., sensitivity, specificity, accuracy, throughput) for the Rusch Optosafe itself. It relies on the predicate device (Williams Airway Intubator K830767) having already met such standards.
2. Sample Size Used for the Test Set and Data Provenance
- Sample Size: Not applicable. This document does not describe a performance study with a test set of patients/samples for the Rusch Optosafe.
- Data Provenance: Not applicable. The "proof" is based on the substantial equivalence to the predicate device, not new data generation for the Optosafe.
3. Number of Experts Used to Establish Ground Truth and Qualifications
- Number of Experts: Not applicable. No ground truth was established by experts for a novel performance study of the Rusch Optosafe. The assessment is regulatory (FDA), not a clinical expert consensus on new data.
- Qualifications of Experts: Not applicable.
4. Adjudication Method for the Test Set
- Adjudication Method: Not applicable. There was no test set requiring adjudication in the context of this 510(k) summary.
5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study
- MRMC Study: No, an MRMC comparative effectiveness study was not done, nor would it typically be expected for this type of device (an airway, not a diagnostic imaging AI).
- Effect Size of Human Readers Improve with AI vs. Without AI Assistance: Not applicable, as this is not an AI-assisted diagnostic device.
6. Standalone (Algorithm Only) Performance Study
- Standalone Study: No, a standalone performance study was not done. This device is a physical medical instrument, not an algorithm.
7. Type of Ground Truth Used
- Type of Ground Truth: The "ground truth" in this context is the established safety and effectiveness of the predicate device (Williams Airway Intubator K830767) as determined by its prior regulatory clearance and market history. No new, independent ground truth was established for the Rusch Optosafe beyond its comparative characteristics.
8. Sample Size for the Training Set
- Sample Size: Not applicable. There is no training set for an AI/algorithm mentioned in this document.
9. How the Ground Truth for the Training Set Was Established
- How Ground Truth Was Established: Not applicable, as there is no training set for an AI/algorithm mentioned.
Ask a specific question about this device
(369 days)
CAE
Ask a specific question about this device
Page 1 of 1